TrademarkDir
SEMNUR PHARMACEUTICALS
LIVE

Serial Number

97729580

Owner

Semnur Pharmaceuticals, Inc.

Attorney

Katherine M. Basile

Filing Date

Dec 22, 2022

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

SEMNUR PHARMACEUTICALS Trademark

Serial Number: 97729580

SEMNUR PHARMACEUTICALS is a trademark filed by Semnur Pharmaceuticals, Inc. on December 22, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Semnur Pharmaceuticals, Inc. (6 trademarks)

Mountain View, CA 94043

Entity Type: 03

Trademark Details

Filing Date

December 22, 2022

Registration Date

Not Registered

Published for Opposition

April 30, 2024

Goods & Services

Pain relief medication; preparations for the relief of pain; injectable pharmaceutical gels for treatment of back pain, lumbosacral radicular pain and sciatica; pharmaceutical preparations, namely, dexamethasone sodium phosphate for medical use for use in the treatment of pain; pharmaceutical preparations, namely, dexamethasone sodium phosphate gel for medical use

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 21, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 21, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 21, 2026 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 21, 2026 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 21, 2026 COAR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 24, 2025 EXRA
SOU EXTENSION 3 GRANTED
Dec 23, 2025 EX3G
SOU EXTENSION 3 FILED
Dec 23, 2025 EXT3
SOU TEAS EXTENSION RECEIVED
Dec 23, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 14, 2025 EXRA
SOU EXTENSION 2 GRANTED
Jun 13, 2025 EX2G
SOU EXTENSION 2 FILED
Jun 13, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Jun 13, 2025 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 28, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 28, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 28, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 28, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 28, 2025 COAR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 3, 2025 EXRA
SOU EXTENSION 1 GRANTED
Nov 20, 2024 EX1G
SOU EXTENSION 1 FILED
Nov 20, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Nov 20, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 25, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 30, 2024 NPUB
PUBLISHED FOR OPPOSITION
Apr 30, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 10, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 25, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 23, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 23, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 23, 2024 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Dec 18, 2023 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Dec 18, 2023 XELR
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Oct 4, 2023 ASCK
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 23, 2023 GNRN
NON-FINAL ACTION E-MAILED
Sep 23, 2023 GNRT
NON-FINAL ACTION WRITTEN
Sep 23, 2023 CNRT
ASSIGNED TO EXAMINER
Sep 22, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 27, 2022 NWOS
NEW APPLICATION ENTERED
Dec 26, 2022 NWAP

Related Trademarks

More from this Owner

SEMDEXA

SEMDEXA

SEMDEXA

SEMDEXA

SEMDEXA

SEMDEXA

SEMDEXA

SEMDEXA

SEMNUR PHARMACEUTICALS

SEMNUR PHARMACEUTICALS

SEMNUR PHARMACEUTICALS

SEMNUR PHARMACEUTICALS